Therna Biosciences
PrivateLast Round
Seed
Aug 26, 2025
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Therna Biosciences operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in August 2025.
Therna Biosciences is a biotechnology company that has developed a biology-guided, AI-powered platform to design and engineer programmable RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therna Biosciences Comparables
Compare Therna Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noara Therapeutics | 85% | |
| Creyon Bio | 85% | |
| Eclipsebio | 82% |
For institutional investors. Book with your work email.
Therna Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Therna Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Seed |
| Pear VC | Seed |
| AIX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 118% MoM.
- Aug 26, 2025
$10M round led by AIX Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 6, 2026
Therna appointed Kevin Green Chief Operating Officer in Aug '26 to lead operations and business development.
- hiresOct 6, 2026
Therna added Dr. Dave Burke, former Arc Institute Chief Technology Officer and Google Android engineering leader, as an AI Advisor to its advisory team in California on Oct 6th '26.
- launchesSep 15, 2026
Therna launches Chronos, a data engine that generates millions of functional RNA measurements, and publicly releases a representative study set for researchers and prospective partners in California on Sep 15th '26.
For institutional investors. Book with your work email.
Therna Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Therna Biosciences's valuation, stock price, and market status.
Is Therna Biosciences a public or private company?
Therna Biosciences is a private company.
What is the current stock price of Therna Biosciences?
Therna Biosciences is a private company, so its shares have no public market price. Caplight tracks Therna Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Therna Biosciences worth (valuation)?
Valuation information for Therna Biosciences is not publicly available.
Can I buy Therna Biosciences stock?
Therna Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Therna Biosciences's last funding round?
Therna Biosciences's most recent funding round was Seed on August 26, 2025.
Who are the main investors in Therna Biosciences?
Key investors in Therna Biosciences include AIX Ventures.
Will Therna Biosciences IPO soon?
No public IPO plans have been announced for Therna Biosciences.
How can I track Therna Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Therna Biosciences's shares on secondary markets.